Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Pace, V. Scafidi, D. Di Bona, L. Siena, S. La Grutta, S. Gallina, R. Speciale, A. Ballacchino, G. Chiappara, C. Bachert, J. Bousquet, M. Gjomarkaj (Palermo, Italy; , Belgium; Montpellier, France). IL-19 as putative biomarker for chronic rhinosinusitis with nasal polyps. Eur Respir J 2010; 36: Suppl. 54, 4316

Member's Comments

No comment yet.

Related content which might interest you: Increased expression of IL-19 in metaplastic epithelium of patients with chronic rhinosinusitis and nasal polyps Source: Annual Congress 2011 - Epithelial cell biology Year: 2011 Effect of mepolizumab on chronic rhinosinusitis symptoms and nasal hypersensitivity in patients with or without nasal polyps Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities Year: 2020 Dupilumab reduces blood and nasal biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps with and without comorbid asthma: SINUS-52 trial Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 Type 2 inflammation-related comorbidities among patients with asthma, chronic rhinosinusitis with nasal polyps, and atopic dermatitis Source: Virtual Congress 2020 – Management of allergy, asthma and COPD Year: 2020 Role of non cholinergic system components in chronic rhinosinusitis and nasal polyps Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 Differential treatment response to mepolizumab in severe eosinophilic asthma with nasal polyps Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 MUC4 overexpression correlates corticoid resistance in chronic rhinosinusitis with nasal polyps Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD Year: 2015 Patient characteristics and treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) in Canada Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 Over-expression of Th17-related cytokines in bronchial and nasal submucosa in severe asthma Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012 Neutrophilic inflammation in nasal lavage (NL) and induced sputum (IS) from patients with chronic sinusitis or chronic sinusitis and asthma Source: Eur Respir J 2003; 22: Suppl. 45, 455s Year: 2003 Mucin 1 downregulation associates with corticoid resistance in chronic obstructive pulmonary disease and chronic rhinosinusitis with nasal polyps Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Incidence of nasal polyposis and its association with the development of chronic bronchitis and/or emphysema Source: Eur Respir J 2002; 20: Suppl. 38, 401s Year: 2002 Impact of mepolizumab in severe asthma with nasal polyps Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 Nasal mucosa biopsy in severe astma patiens as a tool for the prediction of the inflammatory changes in lower airways Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 The upper airways in severe asthma Source: Eur Respir Mon 2011; 51: 189-199 Year: 2011 Interleukin-13 and -4 expression in the central airways of smokers with chronic bronchitis Source: Eur Respir J 2003 Oct 01;22(4):602-608 Year: 2003 Impact of biologic therapy in severe asthma with nasal polyps Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Dupilumab improves all ACQ-5 individual items in patients with chronic rhinosinusitis with nasal polyposis (CRSwNP) and asthma: results from a phase 2a trial Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Mepolizumab reduces nasal symptoms in asthmatic patients with chronic rhino-sinusitis and nasal polyposis: a 12 months real-life study Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020